共同接种?美国社会资本、正式公共卫生规则与COVID-19疫苗接种率的互补性
研究利用县级COVID-19疫苗接种、社会资本以及个人自由与公共卫生价值观数据,分析疫苗接种率与社会资本、正式公共卫生规则及个人价值观的交互关系。发现接种率取决于个人价值观、社会资本水平及二者交互作用,社会资本可正向或负向中介个人价值观对接种率的影响,结果在多种设定下稳健。
要点
- 疫苗接种率取决于个人价值观、社会资本水平及二者交互作用。
- 社会资本对个人价值观的中介作用可正向或负向影响接种率。
- 个人与社区因素独立于政府正式公共卫生措施影响接种决策。
核心结论
- 疫苗接种率取决于个人价值观、社会资本水平及二者的交互作用,社会资本可正向或负向中介个人价值观对接种率的影响。
- 个人及其进入和离开的社区在接种决策中起重要作用,且独立于正式的政府公共卫生措施。
研究设计与样本
- 研究使用县级COVID-19疫苗接种、社会资本以及个人自由与公共卫生价值观数据进行分析。
- 研究提出新框架分析社会资本与个人价值观的交互作用。
- 结果在纳入相关控制变量和多种设定下稳健。
主要发现
- 疫苗接种率取决于个人价值观、社会资本水平及二者的交互作用。
- 社会资本中介个人所持有的价值观,可正向或负向影响疫苗接种率。
- 结果在纳入相关控制变量和多种设定下稳健。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 vaccine rates provide a unique opportunity to explore vaccine hesitancy and potential interactions between social capital and individual, normative values, namely for public health and/or personal freedom. While economists and public health scholars realize the independent effects social capital and stringent public health rules have on prevalence and mortality rates, few recognize how these factors influence vaccination rates. We advance this literature with a novel framework to analyze these interactions. With county-level data on COVID-19 vaccinations, social capital, and measures of the values people have for personal freedom and public health, we find that vaccination rates depend on individual values, the level of social capital, and the interaction between the two. Social capital mediates the values people hold dear, which can influence vaccination rates in positive and negative ways. Our results are robust to the inclusion of relevant controls and under multiple specifications. These results suggest that individuals and the communities people enter into and exit out of play an important role in decisions to vaccinate, which are independent of formal, governmental public health measures.
引用
- Carson B, Isaacs J, Carilli T, et al. Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States. Vaccine. 2022. PMID: 35610104. doi:10.1016/j.vaccine.2022.05.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。